# Saussurea involucrata Cultures for High-Altitude Illness: Enhancing Hypoxia Tolerance and Protecting Against Acute/Chronic Hypoxic Injury

**Authors:** Jinyu Zhao, Yutong Li, Fan Wang, Kangjie Jia, Ge Lou, Huihui Shao, Mingji Jin, Zhonggao Gao, Xianfu Wu, Shuangqing Wang

PMC · DOI: 10.3390/nu18040556 · Nutrients · 2026-02-07

## TL;DR

This study shows that Saussurea involucrata cultures can improve tolerance to high-altitude hypoxia and protect against hypoxic injury in animal models.

## Contribution

The study provides a systematic preclinical evaluation of SICs for high-altitude illness with a focus on endothelial and oxidative stress pathways.

## Key findings

- SICs significantly enhanced acute hypoxia tolerance in mice at 10,000 m.
- SICs modulated endothelial and oxidative stress markers in rats under chronic hypoxia.
- Medium doses of SICs showed optimal efficacy with limited effects on organ remodeling.

## Abstract

Objective: To systematically evaluate the potential of Saussurea involucrata cultures (SICs) against high-altitude illness under hypobaric hypoxia and establish a progressive experimental evidence chain covering acute hypoxia tolerance enhancement and acute/chronic hypoxic injury protection. Methods: A tiered experimental strategy was employed. Key findings were derived from primary rat models of acute (5500 m, 8 h) and chronic intermittent (5500 m, 8 h/d, 4–8 weeks) hypobaric hypoxia. A mouse acute tolerance model (10,000 m lethality, closed-system endurance) provided supplementary verification. Comprehensive analyses included survival, hemorheology, multi-organ function, and core mechanistic indicators of endothelial function and oxidative stress. Diamox, Rhodiola, and Compound Danshen Dripping Pills served as positive controls. Normoxic/hypoxic blank groups served as negative controls. Results: SICs significantly enhanced acute hypoxia tolerance in mice. In the rat models, SICs demonstrated dose-dependent and selective regulation of the endothelial–oxidative stress/hemorheology axis. Specifically, it downregulated endothelin-1, upregulated nitric oxide, enhanced total antioxidant capacity, and improved chronic hypoxia-induced blood hyperviscosity. Medium doses showed consistent optimal efficacy. SICs had limited effects on macroscopic organ remodeling. Conclusions: The core protective effect of SICs lies in enhancing hypoxic tolerance and selectively modulating the interconnected pathways of endothelial function, oxidative stress, and microcirculatory health. This mechanistic profile supports its potential as a preventive or early adjuvant intervention for high-altitude illness, providing a systematic preclinical foundation for translational development.

## Linked entities

- **Species:** Rattus norvegicus (taxon 10116), Mus musculus (taxon 10090)

## Full-text entities

- **Genes:** Alb (albumin) [NCBI Gene 11657] {aka Alb-1, Alb1, BCL001, BCL002, BPL001}, Nos3 (nitric oxide synthase 3, endothelial cell) [NCBI Gene 18127] {aka 2310065A03Rik, Nos-3, eNOS, ecNOS}, Alb (albumin) [NCBI Gene 24186] {aka Alb1, Albza}, Edn1 (endothelin 1) [NCBI Gene 24323] {aka Et1}, Tac1 (tachykinin, precursor 1) [NCBI Gene 24806] {aka PPTA3, Ppt5fl, RATPPTA3, TAC}, EDN1 (endothelin 1) [NCBI Gene 1906] {aka ARCND3, ET1, HDLCQ7, PPET1, QME}
- **Diseases:** Endothelial dysfunction (MESH:D014652), altitude sickness (MESH:D000532), gastrointestinal disturbances (MESH:D005767), pulmonary vascular remodeling (MESH:D066253), multi-organ functional impairment (MESH:D019965), electrolyte (MESH:D014883), pulmonary edema (MESH:D011654), endothelial injury (MESH:D057772), hyperglycemia (MESH:D006943), multi (MESH:D015161), injuries (MESH:D014947), inflammatory (MESH:D007249), hepatic or renal impairment (MESH:D008107), headache (MESH:D006261), blood hyperviscosity (MESH:D006402), sleep disturbances (MESH:D012893), Lipid metabolism disorders (MESH:D052439), death (MESH:D003643), hyperplasia (MESH:D006965), hematopoietic abnormalities (MESH:D019337), acute (MESH:D000208), vascular lipid deposition (MESH:D011017), myocardial enzyme spectrum (MESH:C579922), H (MESH:D000848), glucose (MESH:D018149), Metabolic disorders (MESH:D008659), vasospasm (MESH:D020301), Illness (MESH:D002908), pulmonary hypertension (MESH:D006976), Hypoxia (MESH:D000860), cognitive impairment (MESH:D003072), microcirculatory disorders (MESH:D009358), liver, heart, and kidney injuries (MESH:D006333), multi-organ dysfunction (MESH:D009102), kidney (MESH:D007674), Hypoxic (MESH:D002534), cerebral edema (MESH:D001929), weight gain (MESH:D015430), liver injury (MESH:D017093), polycythemia (MESH:D011086), Myocardial injury (MESH:D009202), fatigue (MESH:D005221)
- **Chemicals:** UA (MESH:D014527), Diamox (MESH:D000086), HCY (MESH:D006710), Syringin (MESH:C028305), TBIL (MESH:D001663), MDA (MESH:D008315), triglyceride (MESH:D014280), SICs (-), Oxygen (MESH:D010100), soda lime (MESH:C004569), glycolipid (MESH:D006017), Blood glucose (MESH:D001786), reactive oxygen species (MESH:D017382), CR (MESH:D003404), glucose (MESH:D005947), NO (MESH:D009569), cholesterol (MESH:D002784), flavonoids (MESH:D005419), CO2 (MESH:D002245), Danshen Dripping Pills (MESH:C000604051), water (MESH:D014867), terpenoids (MESH:D013729), urea nitrogen (MESH:C530477), Lipid (MESH:D008055)
- **Species:** Mus musculus (house mouse, species) [taxon 10090], Rattus norvegicus (brown rat, species) [taxon 10116], Homo sapiens (human, species) [taxon 9606], Saussurea involucrata (species) [taxon 200489], Lotus (genus) [taxon 3867]
- **Cell lines:** SICs-H — Rattus norvegicus (Rat), Adenocarcinoma of the rat prostate, Cancer cell line (CVCL_Y658)

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12942915/full.md

## Figures

9 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12942915/full.md

## References

36 references — full list in the complete paper: https://tomesphere.com/paper/PMC12942915/full.md

---
Source: https://tomesphere.com/paper/PMC12942915